These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38189941)

  • 61. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats.
    Beck O; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2018 Apr; 56(4):256-263. PubMed ID: 28895757
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do police arrestees substitute legal highs for other drugs?
    Wilkins C; Parker K; Prasad J; Jawalkar S
    Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthetic cathinones: a new public health problem.
    Karila L; Megarbane B; Cottencin O; Lejoyeux M
    Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.
    Varì MR; Mannocchi G; Tittarelli R; Campanozzi LL; Nittari G; Feola A; Umani Ronchi F; Ricci G
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33238595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.
    Miliano C; Serpelloni G; Rimondo C; Mereu M; Marti M; De Luca MA
    Front Neurosci; 2016; 10():153. PubMed ID: 27147945
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Psychotic-Like Experiences and Concurrent Substance Use Among People Who Use New Psychoactive Substances.
    Ellilä V; Levola J; Denissoff A; Partanen M; Niemelä S
    Subst Use Misuse; 2023; 58(12):1606-1614. PubMed ID: 37482647
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel psychoactive substance and other drug use by young adults in Western australia.
    Goggin LS; Gately N; Bridle RI
    J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
    Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey.
    Göl E; Çok I
    Forensic Sci Int; 2019 Jan; 294():113-123. PubMed ID: 30502695
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
    Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
    Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas.
    Martinotti G; Lupi M; Carlucci L; Cinosi E; Santacroce R; Acciavatti T; Chillemi E; Bonifaci L; Janiri L; Di Giannantonio M
    Hum Psychopharmacol; 2015 Jul; 30(4):295-301. PubMed ID: 26216566
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R; Mannocchi G; Pantano F; Romolo FS
    Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New Psychoactive Substances in Pediatric Patients.
    Warrick BJ; Tataru AP; Gerona R
    Pediatr Clin North Am; 2017 Dec; 64(6):1223-1241. PubMed ID: 29173782
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
    Rychert M; Wilkins C; Parker K; Witten K
    Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.
    Tanti M; Cosgrove J; Kelleher C; Jones R; Maguire M
    Clin Med (Lond); 2021 May; 21(3):189-194. PubMed ID: 33947659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nephrotoxic effects of designer drugs: synthetic is not better!
    Luciano RL; Perazella MA
    Nat Rev Nephrol; 2014 Jun; 10(6):314-24. PubMed ID: 24662435
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.